Professor Gordon Wishart is a consultant breast & endocrine surgeon, former director of the Cambridge Breast Unit (2005-2010),Cambridge University Hospital NHS Foundation Trust and Visiting Professor of Cancer Surgery at Anglia Ruskin University, Cambridge. Professor Wishart has a national and international reputation in the field of breast cancer and has published widely in the field of breast surgery, endocrine surgery and breast cancer.
Professor Wishart now works as an independent practitioner in Cambridge as well as pursuing his many research interests and medico-legal practice. This web site is intended to provide further information and up to date contact details for all aspects of his clinical, medico-legal and research activities.
Professor Gordon Wishart graduated MB ChB from the University of Edinburgh in 1983 followed by an MD in 1992 for a thesis entitled "Aspects of multidrug resistance in breast cancer". Professor Wishart received fellowships from the Royal College of Physicians and Surgeons of Glasgow in 1987 and the Royal College of Surgeons of England in 2001. Following his first consultant appointment in Sussex in 1995, Professor GC Wishart moved to Addenbrooke's Hospital, Cambridge in 1998 to take up the post of consultant breast & endocrine surgeon with a remit to develop and modernise breast cancer services. Professor Gordon C Wishart was Director of the Cambridge Breast Unit from 2005 to 2010 and was appointed as Visiting Professor of Cancer Surgery at Anglia Ruskin University, Cambridge in December 2008.
Professor Wishart has a national and international reputation in the field of breast cancer and has published widely in the field of breast cancer, including sentinel node biopsy, endocrine surgery and breast cancer. A full list of his publications is listed below and can also be found on the PubMed website by searching for Wishart GC. In some of his research articles he will be listed as GC Wishart. Professor Gordon Wishart was instrumental in raising £2 million to build the Cambridge Breast Cancer Research Unit in 2008, a clinical and laboratory facility to support the clinical research programme. He is the lead or co-investigator on clinical trials that have attracted over £2 million in grant funding. He has recently been an advisor to the Department of Health as part of the cancer waiting times and national cancer survivorship initiatives.
Professor Wishart's main areas of research interest include factors that lead to variation in breast cancer survival and the effect of screen-detection on survival. He recently led a team of clinicians and scientists to produce a new model, Predict, that estimates the survival and treatment benefits following surgery for invasive breast cancer (www.predict.nhs.uk). The second version of Predict, launched in July 2011, is the first clinical prognostication model for breast cancer to include HER2 and the benefit of trastuzumab (Herceptin).
With many years of clinical experience, and an active research interest in the prediction of breast cancer survival, Professor Gordon Wishart is in an ideal position to provide expert witness medical reports on cases of clinical negligence related to breast cancer diagnosis and treatment, especially delay in diagnosis.
Professor Gordon Wishart graduated MB ChB from the University of Edinburgh in 1983 and underwent his general surgery training in Glasgow from 1984-2005, being one of the first surgical trainees to pass the third part and exit exam of the general surgical fellowship with a special interest in breast cancer surgery. As a consultant general surgeon with a special interest in breast surgery he introduced specialist breast cancer services to the Princess Royal Hospital, West Sussex from 1995 to 1998 after which he moved to Cambridge to further specialise as a breast & endocrine surgeon at Cambridge University Hospital NHS Foundation Trust from 1998 to 2011. Professor GC Wishart was the Director of the Cambridge Breast Unit from 2005 to 2010.
As the most senior Cambridge breast cancer surgeon, Professor Wishart now provides a full range of breast cancer surgery including wide local excision (lumpectomy), simple mastectomy, skin sparing mastectomy, sentinel node biopsy and axillary clearance. Professor Wishart was one of the national trainers during introduction of the national sentinel node training programme from 2005 to 2007. As a surgical oncologist Professor Wishart is keen to maintain a balance between good breast cancer surgery and the cosmetic appearance of the breast by use of simple oncoplastic techniques and immediate breast reconstruction surgery at the time of mastectomy for either invasive or non-invasive breast cancer.
Since 1995 Professor Wishart has been passionate about making immediate breast reconstruction surgery available to women undergoing mastectomy. By use of a skin-sparing mastectomy technique, and collaboration with highly skilled breast reconstructive and plastic surgeons who can offer a full range of reconstructive surgery, Professor Wishart has now gained over 16 years experience of immediate breast reconstruction and has trained many colleagues in skin-sparing mastectomy and axillary clearance through small central incisions after removal of the nipple and areola. By close collaboration with breast reconstruction surgeons, and synchronous surgery by breast cancer and reconstruction teams, operation times for skin-sparing mastectomy and immediate breast reconstruction can be greatly reduced contributing to a quicker recovery and less time in hospital.
As well as specialist training in breast cancer surgery, Professor Wishart also trained in thyroid and parathyroid endocrine surgery and has been one of the pioneers of minimally invasive, or focused parathyroidectomy for primary hyperparathyroidism in the UK.
AvMA's 24th Annual Clinical Negligence Conference
Professor Gordon Wishart, a leading UK consultant breast cancer surgeon and Professor of Cancer Surgery at Anglia Ruskin University Cambridge, will give the keynote address entitled "Cancer and Life Expectancy" on Saturday 23 June 2012 at the 24th Annual Clinical Negligence Conference (ACNC) organised by AvMA (Action against Medical Accidents).
The 2012 ACNC will take place at the Hilton Brighton Metropole on 22-23 June, and will offer a high standard of plenary presentations and focused breakout sessions from leading medical and legal experts that make this the event for clinical negligence specialists.
In his Keynote address Professor Wishart will cover a variety of topics including current survival statistics for common types of cancer, variation in cancer services and cancer survival throughout the UK and the role of cancer screening.
Professor Wishart has a busy medico-legal practice where he specialises in cases of clinical negligence related to breast cancer diagnosis and treatment. He has over 16 years clinical experience as a consultant breast surgeon in Cambridge and Sussex and has published widely in the field of clinical breast cancer research. As the pioneer of the recently launched breast cancer survival and treatment prediction model PREDICT (www.predict.nhs.uk), Professor Wishart is ideally placed to advise both defence solicitors and claimants as a breast cancer expert witness, on both breach of duty and causation, in cases where there has been a delay in diagnosis of breast cancer.